Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection.

Four Canadian studies have suggested that receipt of seasonal influenza vaccine increased the risk of laboratory-confirmed infection with 2009 pandemic influenza A(H1N1). During the influenza season of 2009 in Victoria, Australia, this virus comprised 97% of all circulating influenza viruses for which sub-typing was available. We found no evidence that seasonal influenza vaccine increased the risk of, or provided protection against, infection with the pandemic virus. Ferret experiments have suggested protection against pandemic influenza A(H1N1) 2009 from multiple prior seasonal influenza infections but not from prior seasonal vaccination. Modelling studies suggest that influenza infection leads to heterosubtypic temporary immunity which is initially almost complete. We suggest these observations together can explain the apparent discrepant findings in Canada and Victoria. In Victoria there was no recent prior circulation of seasonal influenza and thus no temporary immunity to pandemic influenza. There was no association of seasonal influenza vaccine with pandemic influenza infection. In Canada seasonal influenza preceded circulation of the pandemic virus. An unvaccinated proportion of the population developed temporary immunity to pandemic influenza from seasonal infection but a proportion of vaccinated members of the population did not get seasonal infection and hence did not develop temporary immunity to pandemic influenza. It may therefore have appeared as if seasonal vaccination increased the risk of infection with pandemic influenza A(H1N1) virus.

[1]  I. Barr,et al.  Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, Singapore , 2010, Emerging infectious diseases.

[2]  G. Kobinger,et al.  Assessment of the Efficacy of Commercially Available and Candidate Vaccines against a Pandemic H1N1 2009 Virus , 2010, The Journal of infectious diseases.

[3]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[4]  Eduardo Lazcano-Ponce,et al.  Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City , 2009, BMJ : British Medical Journal.

[5]  Alberto Arnedo-Pena,et al.  Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. , 2010, Vaccine.

[6]  T. Tumpey,et al.  Pathogenesis of 1918 Pandemic and H5N1 Influenza Virus Infections in a Guinea Pig Model: Antiviral Potential of Exogenous Alpha Interferon To Reduce Virus Shedding , 2009, Journal of Virology.

[7]  A. Osterhaus,et al.  Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus , 2009, PloS one.

[8]  D. Skowronski,et al.  Selection bias explains seasonal vaccine’s protection , 2009, BMJ : British Medical Journal.

[9]  L. Malmgaard.  Induction and regulation of IFNs during viral infections. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  Laura C. Rosella,et al.  Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.

[11]  I. Bergeri,et al.  Pandemic H1N1 influenza surveillance in Victoria, Australia, April - September, 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  Akira Sasaki,et al.  Coexistence conditions for strains of influenza with immune cross-reaction. , 2010, Journal of theoretical biology.

[13]  Emma S McBryde,et al.  Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9 , 2010, BMC infectious diseases.

[14]  H. Kelly,et al.  Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  G. Kochs,et al.  Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in Ferrets , 2009, Journal of Virology.

[16]  Neil Ferguson,et al.  Improving the realism of deterministic multi-strain models: implications for modelling influenza A , 2008, Journal of The Royal Society Interface.

[17]  Deborah Middleton,et al.  Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. , 2010, The Journal of infectious diseases.

[18]  A Linde,et al.  Does viral interference affect spread of influenza? , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  Neil Ferguson,et al.  Incorporating demographic stochasticity into multi-strain epidemic models: application to influenza A , 2009, Journal of The Royal Society Interface.

[20]  S. S. Sherman,et al.  Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Skowronski,et al.  Seasonal vaccine effectiveness against pandemic A/H1N1 , 2010, The Lancet.

[22]  T Sonoguchi,et al.  Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. , 1985, The Journal of infectious diseases.

[23]  A. García-Sastre,et al.  Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines , 2010, PLoS pathogens.

[24]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[25]  D. Mak,et al.  Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  L. Balluz,et al.  Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[27]  A. García-Sastre,et al.  Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment , 2009, Journal of Virology.

[28]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[29]  Víctor Hugo Borja-Aburto,et al.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis , 2009, The Lancet.

[30]  J P Fox,et al.  Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. , 1982, American journal of epidemiology.

[31]  S. An,et al.  The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. , 1959, Bulletin of the World Health Organization.

[32]  C. Reed,et al.  Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Derek A T Cummings,et al.  Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. , 2009, The New England journal of medicine.

[34]  Francesca Tria,et al.  A minimal stochastic model for influenza evolution , 2005, q-bio/0505035.